Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 7876 - 7900 of 9327 in total
CX-717 is an ampakine compound previously investigated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and Alzheimer's disease.
Illicit
Investigational
Chlorfenson is developed by Moberg Derma for the treatment of onychomycosis (nail fungus) as the primary indication.
Investigational
Talinolol has been investigated for the basic science of Gastrointestinal Motility Disorder.
Investigational
Verinurad has been used in trials studying the basic science and treatment of Gout, Gout and Hyperuricemia, and Gout and Asymptomatic Hyperuricemia.
Investigational
Timonacic has been used in trials studying the treatment of HIV Infections.
Investigational
LY518674 has been used in trials studying the treatment of Metabolic Syndrome X.
Investigational
MK-0873 has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
Experimental
Experimental
Nacubactam is under investigation in clinical trial NCT03174795 (A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection).
Investigational
Experimental
Investigational
Aprobarbital is a barbiturate derivative synthesized in the 1920s by Ernst Preiswerk. It was determined that the substance was capable of demonstrating sedative, hypnotic, and anticonvulsant effects. A primary treatment indicated for the use of aprobarbital was subsequently insomnia. Aprobarbital was never as widely used as more common barbiturate derivatives...
Experimental
Illicit
Heptabarbital is an intermediate or short term barbiturate used mainly for sedation and hypnosis.
Experimental
A deaminated metabolite of levodopa. [PubChem]
Experimental
Experimental
Displaying drugs 7876 - 7900 of 9327 in total